{
  "timestamp": "20250104_024925",
  "model": "gpt-4o",
  "interaction_type": "answer_normal_rag",
  "question_id": "427393cb",
  "question_text": "Which of the following drug is contraindicated in a patient of myasthenia gravis: September 2008",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on retrieved medical knowledge."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.Please help answer this multiple choice question:\n\n    Question: Which of the following drug is contraindicated in a patient of myasthenia gravis: September 2008\n\n    Options:\n    opa. Succinylcholine\nopb. Tubocurare\nopc. Pyridostigmine\nopd. Halothane\n\n### Retrieved Similar Medical Knowledge:\n- Vasculitis CAUSES Thrombosed aneurysm\n- PROK2 INTERACTS_WITH EIF2S1\n- Pharmacologic Substance TREATS Myasthenia Gravis\n- ALDH3A1 gene|ALDH3A1 PART_OF Exosomes\n- Wall of intestine LOCATION_OF Bacteria, Anaerobic\n- agonists TREATS Myasthenia Gravis\n- Pyridostigmine TREATS Myasthenia Gravis, Generalized\n- Neuromuscular Blocking Agents TREATS Myasthenia Gravis\n- hyperfunction ASSOCIATED_WITH HLA-Bw51\n- Anesthetics TREATS Myasthenia Gravis\n- Pharmaceutical Preparations COMPLICATES Myasthenia Gravis\n\n    ### Instructions:\n            - Use standard medical knowledge as the primary guide.\n            - Consider enhanced information only if it aligns with consensus.\n            - If conflicting or unclear, present the most likely correct answer based on known facts.\n            - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n    ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n                \n    ### Output Format\n    Provide your response in valid JSON format:\n    {   \n        \"final_analysis\": \"Your analysis of how the retrieved relationships support the answer\",\n        \"answer\": \"Option key from the available options (only key, like opa)\",\n        \"confidence\": Score between 0-100 based on evidence strength and relevance\n    }\n    "
    }
  ],
  "response": "```json\n{\n    \"final_analysis\": \"Succinylcholine is a depolarizing neuromuscular blocker that can exacerbate muscle weakness in patients with myasthenia gravis due to their already compromised neuromuscular transmission. Tubocurare, a non-depolarizing neuromuscular blocker, is also contraindicated as it can cause prolonged paralysis in these patients. Pyridostigmine is used to treat myasthenia gravis, and halothane, an anesthetic, does not have a direct contraindication in myasthenia gravis. However, among the options, succinylcholine is more commonly recognized as contraindicated due to its potential to cause severe muscle weakness and respiratory failure in myasthenic patients.\",\n    \"answer\": \"opa\",\n    \"confidence\": 90\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4o",
    "temperature": 0.0
  }
}